UOB share price hits record high after Macquarie upgrade, buyback filing

UOB share price hits record high after Macquarie upgrade, buyback filing

Singapore, Jan 23, 2026, 14:49 SGT — Regular session.

  • Shares of United Overseas Bank jumped roughly 4.3% in afternoon trading, hitting a new high of S$39.41
  • Broker upgrades sparked a rally that boosted other Singapore lenders as well
  • Investors are focusing on UOB’s results due out February 24

Shares of United Overseas Bank (UOB) climbed 4.3% to S$39.23 in mid-afternoon trading on Friday in Singapore, after hitting a fresh record peak at S$39.41 earlier in the session. (Google)

The move pushed Singapore’s third-largest listed bank toward its best close ever, while the heavyweight Straits Times Index hovered near record territory. OCBC also reached fresh highs, according to the Business Times. (The Business Times)

This rally is pulling double duty: betting on banks weathering earnings season and snapping back after some investors skipped UOB’s late-2025 dip. Macquarie’s Jayden Vantarakis bumped the stock to “outperform” and raised his target to S$41, tagging it a likely “relative-value catch-up play.” (The Business Times)

UOB maintained its pace with capital moves, revealing in a daily buy-back notice that it snapped up 37,000 shares on Jan. 22 and cancelled them. The bank paid between S$36.88 and S$37.62 per share. (Siasset)

UOB’s Sydney branch priced A$2.0 billion in senior unsecured notes maturing in 2031. The deal breaks down into A$750 million of floating-rate notes at 3-month BBSW plus 0.72%, and A$1.25 billion of fixed-rate notes at 5.023%. (BBSW is a key Australian short-term interest-rate benchmark.)

The risk hasn’t disappeared. When benchmark rates drop, net interest margins — the gap between loan earnings and deposit costs — can get squeezed. UOB has demonstrated it’s willing to set aside hefty credit allowances to build cushions when needed. (Reuters)

Friday’s rally leaves scant margin for error if revenue from trading, fees, or wealth inflows slows, or if the bank flags rising credit costs.

UOB will release its full-year 2025 results on Feb. 24, ahead of the market open. Investors will be watching closely for updates on dividends, capital returns, and credit quality. (Sgx)

Stock Market Today

  • Genetic Engineering Tool Market Set to Reach $28.57 Billion by 2031 Driven by CRISPR Advances
    January 23, 2026, 6:51 AM EST. The Global Genetic Engineering Tool Market is forecast to grow at a 4.38% CAGR, expanding from $22.09 billion in 2025 to $28.57 billion by 2031. Key growth drivers include rapid technological progress in genome editing platforms like CRISPR-Cas9, which is transitioning from lab research to clinically approved therapies. Notably, the FDA's approval of CASGEVY underscores the commercial viability of gene-edited treatments. Increased funding in biotech and genomics fuels demand for advanced tools and instrumentation. However, stringent regulatory frameworks and ethical concerns over off-target effects delay clinical advances, hindering the shift to large-scale commercial tool procurement. Despite robust investment and nine new product approvals reported in 2024, regulatory hurdles remain a critical challenge for market expansion.
ANZ share price slips after Suncorp job-cut row as RBA rate bets tighten
Previous Story

ANZ share price slips after Suncorp job-cut row as RBA rate bets tighten

Woodside Energy share price slips ahead of Australia Day break as oil swings; ASX:WDS Q4 report looms
Next Story

Woodside Energy share price slips ahead of Australia Day break as oil swings; ASX:WDS Q4 report looms

Go toTop